Alignment Healthcare (ALHC Quick QuoteALHC - Free Report) reported $1.36 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 36.7%. EPS of -$0.04 for the same period compares to $0.02 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.31 billion, representing a surprise of +3.63%. The company has not delivered EPS surprise, with the consensus EPS estimate being -$0.04.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Alignment Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Medical benefits ratio: 89.5% versus the four-analyst average estimate of 88.9%.
• Health Plan Membership - Ending: 301,200 versus 297,053 estimated by four analysts on average.
• Revenues- Other: $10.03 million compared to the $9 million average estimate based on two analysts. The reported number represents a change of +0.2% year over year.
• Revenues- Earned premiums: $1.35 billion versus $1.3 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +37.1% change.

View all Key Company Metrics for Alignment Healthcare here>>>

Shares of Alignment Healthcare have returned +0.3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.